C
Constitution Medical Investors
Hematology testing system for blood disease diagnosis
About Constitution Medical Investors
Constitution Medical Investors, Inc. (CMI) was a medical device company based in Boston, Massachusetts, that specialized in developing innovative hematology testing systems. The company was formed in 2008 through a partnership between the private equity firm Warburg Pincus and senior healthcare executives Patrick Sullivan and Daniel Levangie, who were former executives at Cytyc Corporation. The founders aimed to identify and acquire innovative healthcare-related technologies where they could apply their experience in product development and commercialization.
CMI's flagship product was the Bloodhound™ technology, a fully-automated system designed to provide faster and more accurate diagnosis of blood-related diseases like anemia and leukemia. This system was developed to increase laboratory efficiency by consolidating several workstations into a single, compact unit capable of counting, identifying, and categorizing blood cells and platelets. The company operated in the laboratory hematology testing market, which had an estimated global size of over $2.0 billion in 2011.
In July 2013, Roche Diagnostics acquired Constitution Medical Investors for an upfront payment of $220 million, with potential for further milestone-based payments. Following the acquisition, CMI was designated to become a center of excellence in hematology within Roche Diagnostics, continuing its development of hematology technology on a global scale. Patrick Sullivan served as the Chairman and CEO of CMI at the time of the acquisition.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2012 | $12M | $49M | Undisclosed | — |
| EARLY VC✓Equity / VC | Mar 2011 | $20M | $80M | Undisclosed | — |
Growth signals
Latest recorded traffic for Constitution Medical Investors is 110 monthly website visits. Constitution Medical Investors's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Constitution Medical Investors in the Boston ecosystem
The Constitution Medical Investors office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Constitution Medical Investors on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Constitution Medical Investors’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







